Clinical Trial Update: NeoTAILOR: ABiomarker-directed Approach to Guide Neoadjuvant Therapy for Patients With Stage II/III ER-positive, HER2-negative Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial update for NeoTAILOR, a biomarker-directed approach to guide neoadjuvant therapy in patients with stage II/III ER-positive, HER2-negative breast c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Washington University School of Medicine | Conditions: Breast Cancer, Cancer of the Breast | Phase 2 | Status: RECRUITING